Abstract
Thirty-five years of single-center experience in cardiac myxoma surgery and related postoperative complications
- Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
- Department of Cardiac and Vascular Surgery, Medical University of Gdansk, Gdansk, Poland
Introduction
Myxoma is the most common benign primary cardiac tumor.
Aim
To present a single center’s 35-year experience with myxoma surgery in terms of surgical technique and postoperative complications.
Material and methods
The data of 166 patients (56.7 ±12.6 years old, 68.1% female) with surgically removed myxoma were retrospectively analyzed. Information on blood transfusions, additional procedures and postoperative complications was collected.
Results
A median sternotomy was performed in 97.5% of patients. A right mini-thoracotomy was performed in 4 patients. Most (95.2%) patients were semi-urgent. The reason for truly urgent surgery was hemodynamic instability in 4.8% of patients. Crystalloid cardioplegia was used in 62% of cases. Postoperative complications were observed in 12% of patients. One death was observed on the first postoperative day. During hospitalization, 6 deaths (3.6%) were observed. The most common cause of death was multisystemic organ failure. There were no gender differences in mortality and complications.
Conclusions
Surgical treatment of myxomas is a relatively safe procedure with a mortality rate comparable to other types of cardiac surgery. The postoperative complication rate is low. Gender has no influence on the complication rate or type.
Keywords
cardiac myxoma, cardio‑oncology, benign tumors, surgical treatment
Coverage in
Integrated with
